Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
525882
Reference Type
Journal Article
Title
SMRT recruitment by PPAR gamma is mediated by specific residues located in its carboxy-terminal interacting domain (vol 259, pg 43, 2006)
Author(s)
Sutanto, MM; Symons, MS; Cohen, RN
Year
2007
Is Peer Reviewed?
1
Journal
Molecular and Cellular Endocrinology
ISSN:
0303-7207
EISSN:
1872-8057
Volume
267
Issue
1-2
Page Numbers
137-143
Language
English
DOI
10.1016/j.mce.2006.11.003
Abstract
The silencing mediator of retinoid and thyroid hormone receptors (SMRT) has been shown to play an important role in adipogenesis and PPAR gamma transcriptional activity. SMRT contains two interacting domains that mediate interactions with nuclear receptors. Interestingly, SMRT is recruited to PPAR gamma via its C-terminal interacting domain, and mutation of the proximal interacting domain does not interfere with recruitment via PPAR gamma. To understand how the distal interacting domain mediates recruitment by PPAR gamma, we have now mutated residues in this domain to the corresponding amino acids found in the proximal domain. We show that specific residues in this distal domain are vital for interactions with PPAR gamma, but not for a related receptor, RAR alpha. Furthermore, naturally occurring SMRT isoforms that differ in interacting domain sequences have different effects on PPAR gamma as opposed to RARa recruitment. These data suggest that PPAR gamma and RAR alpha interact with SMRT via distinct mechanisms. These differences will be important as ligands are designed that lead to specific patterns of nuclear receptor recruitment of corepressors. Published by Elsevier Ireland Ltd.
Keywords
nuclear hormone-receptors; transcriptional activity; insulin-resistance; co-repressor; corepressors; ligand
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity